P57.8

Clinical Causes: Severe jaundice in newborns due to hemolytic diseases like Rh or ABO incompatibility Gastrointestinal or metabolic disorders that impair bilirubin breakdown Infections that affect the liver or biliary system Genetic conditions affecting bilirubin metabolism Delayed or inadequate treatment of neonatal jaundice

Key Symptoms: Lethargy or extreme sleepiness Muscle tone abnormalities such as rigidity or floppiness High-pitched crying Involuntary movements or seizures Feeding difficulties Poor feeding or irritability Abnormal eye movements Arching of the body or arching movements (retrocollis and opisthotonus)

Diagnosis Path: Diagnosis involves a combination of clinical observation and laboratory tests. Key steps include: - Blood tests to measure bilirubin levels - Investigation for underlying causes such as hemolytic disease - Brain imaging studies like MRI to detect any neurological damage - Assessment of gestational age and overall health status - Follow-up examinations to monitor neurological development Ultrasound and other imaging modalities may be used to evaluate any structural brain changes. Early diagnosis is pivotal to manage the condition effectively and reduce the risk of permanent damage.

Treatment Protocols: The management of other specified kernicterus includes: - Phototherapy: Using special lights to reduce bilirubin levels in the blood - Exchange transfusions: Removing and replacing the baby's blood to quickly lower bilirubin - Addressing underlying causes such as hemolytic disease - Supportive care including ensuring adequate hydration and nutrition - Monitoring for neurological symptoms and seizures - Long-term neurodevelopmental assessments and supportive therapies In some cases, neuroprotective strategies and rehabilitation therapies may be recommended to support developmental progress. Prevention through timely treatment of newborn jaundice is the most effective approach.